All Blogs

Nov 09, 2021

Alcon to acquire Ivantis for USD 475 Million  Alcon announced that it intends to buy glaucoma surgery device maker Ivantis for USD 475 million upfront. Geneva, Switzerland-based Alcon aims to support its portfolio across cataract, refractive, retina and glaucoma offerings by taking over Ivantis and its n...

Nov 08, 2021

Hemophilia is an inherited rare disorder where blood doesn’t clot in the regular way because the person affected doesn’t make enough blood-clotting proteins (clotting factors). Without these factors, patients cannot stop bleeding when they are injured. Patients with more severe forms of the disease can experience s...

Nov 05, 2021

IgA Nephropathy (IgAN), also called Berger’s disease, is an autoimmune rare disease affecting the kidneys. It impairs blood filtration in the kidneys' tiny blood channels. An aberrant protein destroys the filtering unit (glomerulus) inside the kidneys, causing IgA Nephropathy. It is estimated that 20–40% of persons...

Nov 04, 2021

ReValve Solutions, Inc. declares successful first human use of the Transeptal Mitral Valve Replacement  On November 01, 2021, ReValve Solutions, Inc., a company operating in the field of transcatheter structural heart replacement and repair, announced the successful first human use of its transcatheter, Palmetto...

Nov 03, 2021

The technological innovations over the past two to three decades have significantly changed the dynamics of various industries. Healthcare is no exception to it. From online appointments to robotic surgery and from telemedicine to digital payments, almost all the segments of healthcare delivery have immensely revol...

Nov 02, 2021

Magnus Medical’s neurostimulation technology gets FDA breakthrough status to treat MDD Magnus Medical has secured a breakthrough device designation from the US Food and Drug Administration (FDA) for its neurostimulation technology for major depressive disorder (MDD) treatment. The individualised, rapid-acting...

Nov 01, 2021

Progress is driven by innovation. When it comes to developing novel medications and therapeutic biological products, the FDA's Center for Drug Evaluation and Research (CDER) assists the pharmaceutical sector at every stage of the process. CDER offers scientific and regulatory assistance needed to bring innovative m...

Oct 29, 2021

The HIV-1 treatment market for naïve and experienced patients is evolving consistently. Some of the major changes include the preference of single-tablet regimens (STRs) over multiple tablet regimens (MTRs), tenofovir alafenamide (TAF)-based therapies over tenofovir disoproxil fumarate (TDF)-based therapies, integr...

Oct 28, 2021

Naviswiss secures FDA 510k clearance for Naviplan, an advanced planning solution for hip replacement surgery  On October 21, 2021, Naviswiss, a Swiss-based medical technology company, received approval from the FDA to commercialise Naviplan in the United States. Naviplan is a digital pre-operative planning ...

Oct 27, 2021

The Pharmaceuticals segment of the Healthcare Industry has a significant market across the globe, which has grown quite extensively in the past few decades. The pharmaceutical sector has always been at the forefront of drug discovery, development, production, and marketing. The pharmaceutical industry in the twenty...